Varian Completes Purchase of Embolic Bead Asset

Thursday, August 22, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

PALO ALTO, Calif., Aug. 21, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. This acquisition expands the portfolio of Varian interventional oncology solutions.

To view the original announcement from July 2, 2019, visit: https://www.varian.com/news/varian-expand-interventional-oncology-portfolio-purchase-embolic-bead-asset.

About Varian At Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 9,200 employees across 70 countries keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press ContactMark PlungyDirector, Global Public Relations+1 (650) 424-5630 mark.plungy@varian.com

Investor Relations ContactJ. Michael BruffSenior Vice President, Investor Relations+1 (650) 424-5163 investors@varian.com

 

Cision View original content:http://www.prnewswire.com/news-releases/varian-completes-purchase-of-embolic-bead-asset-300905358.html

SOURCE Varian



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store